Literature DB >> 12162728

Soluble flt-1 and the angiopoietins in the development and regulation of placental vasculature.

D Stephen Charnock-Jones1.   

Abstract

One of the key roles of the placenta is to mediate exchange of oxygen, nutrients and waste products between the maternal and fetal circulations. While some nutrients are actively taken up, oxygen is passively transported (i.e. it moves down a simple concentration gradient). To ensure an adequate supply as gestation progresses, the vascular structures in the human placenta remodel to facilitate this transfer. Under conditions in which oxygen is limited, at high altitude for example, these adaptations become more pronounced. In placentae obtained from high altitude the mean diameter of vessels is increased and the number of perivascular cells (pericytes) is reduced. Pericytes play an important role in modulating endothelial cell function and in their absence the endothelial cells are sensitive to growth factor withdrawal. The vascular remodelling that occurs in normal pregnancy is in part mediated by soluble factors (some produced by pericytes) and the level of these may in turn be regulated by local oxygen tension. We have shown that the mRNAs encoding both angiopoietins are present in the placenta and both are regulated by local PO2. Ang-2 mRNA transcription is increased under reduced oxygen and the stability of Ang-1 mRNA is reduced under similar conditions. Thus the ratio of mRNAs encoding these antagonistic factors changes (in favour of Ang-2), in the placenta in response to a reduction in PO2. The adaptations seen in the placenta and the mechanism by which they are achieved may be generally applicable.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12162728      PMCID: PMC1570743          DOI: 10.1046/j.1469-7580.2002.00063.x

Source DB:  PubMed          Journal:  J Anat        ISSN: 0021-8782            Impact factor:   2.610


  65 in total

1.  Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity.

Authors:  Y He; S K Smith; K A Day; D E Clark; D R Licence; D S Charnock-Jones
Journal:  Mol Endocrinol       Date:  1999-04

2.  Altered blood pressure course during normal pregnancy and increased preeclampsia at high altitude (3100 meters) in Colorado.

Authors:  S K Palmer; L G Moore; D Young; B Cregger; J C Berman; S Zamudio
Journal:  Am J Obstet Gynecol       Date:  1999-05       Impact factor: 8.661

3.  A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation.

Authors:  D E Clark; S K Smith; Y He; K A Day; D R Licence; A N Corps; R Lammoglia; D S Charnock-Jones
Journal:  Biol Reprod       Date:  1998-12       Impact factor: 4.285

4.  Developmental expression and regulation of basic fibroblast growth factor and vascular endothelial growth factor in rat decidua and in a decidual cell line.

Authors:  R K Srivastava; Y Gu; S Ayloo; M Zilberstein; G Gibori
Journal:  J Mol Endocrinol       Date:  1998-12       Impact factor: 5.098

5.  Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia.

Authors:  S J Mandriota; M S Pepper
Journal:  Circ Res       Date:  1998-10-19       Impact factor: 17.367

6.  Role of placenta growth factor (PIGF) in human extravillous trophoblast proliferation, migration and invasiveness.

Authors:  A Athanassiades; P K Lala
Journal:  Placenta       Date:  1998-09       Impact factor: 3.481

7.  Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele.

Authors:  P Carmeliet; V Ferreira; G Breier; S Pollefeyt; L Kieckens; M Gertsenstein; M Fahrig; A Vandenhoeck; K Harpal; C Eberhardt; C Declercq; J Pawling; L Moons; D Collen; W Risau; A Nagy
Journal:  Nature       Date:  1996-04-04       Impact factor: 49.962

8.  Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal.

Authors:  L E Benjamin; D Golijanin; A Itin; D Pode; E Keshet
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

9.  Colocalization of acidic and basic fibroblast growth factor (FGF) in human placenta and the cellular effects of bFGF in trophoblast cell line JEG-3.

Authors:  R A Ferriani; A Ahmed; A Sharkey; S K Smith
Journal:  Growth Factors       Date:  1994       Impact factor: 2.511

10.  Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice.

Authors:  G H Fong; L Zhang; D M Bryce; J Peng
Journal:  Development       Date:  1999-07       Impact factor: 6.868

View more
  13 in total

Review 1.  Placental growth factor: What hematologists need to know.

Authors:  Laura F Newell; Shernan G Holtan
Journal:  Blood Rev       Date:  2016-08-27       Impact factor: 8.250

2.  Accreta complicating complete placenta previa is characterized by reduced systemic levels of vascular endothelial growth factor and by epithelial-to-mesenchymal transition of the invasive trophoblast.

Authors:  Mark J Wehrum; Irina A Buhimschi; Carolyn Salafia; Stephen Thung; Mert O Bahtiyar; Erica F Werner; Katherine H Campbell; Christine Laky; Anna K Sfakianaki; Guomao Zhao; Edmund F Funai; Catalin S Buhimschi
Journal:  Am J Obstet Gynecol       Date:  2011-02-12       Impact factor: 8.661

3.  Immunohistochemical expression of von Willebrand factor in the preeclamptic placenta.

Authors:  Mauro Parra-Cordero; Cleofina Bosco; Jaime González; Rodrigo Gutiérrez; Pilar Barja; Ramón Rodrigo
Journal:  J Mol Histol       Date:  2011-08-17       Impact factor: 2.611

4.  Serum Angiogenic and Anti-angiogenic Markers in Pregnant Women with Placenta Percreta.

Authors:  Hacer Uyanıkoğlu; Adnan İncebıyık; Ahmet B Turp; Güler Çakmak; Sibel Sak; Neşe G Hilali
Journal:  Balkan Med J       Date:  2017-09-13       Impact factor: 2.021

5.  Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Authors:  John V Ilekis; Ekaterini Tsilou; Susan Fisher; Vikki M Abrahams; Michael J Soares; James C Cross; Stacy Zamudio; Nicholas P Illsley; Leslie Myatt; Christine Colvis; Maged M Costantine; David M Haas; Yoel Sadovsky; Carl Weiner; Erik Rytting; Gene Bidwell
Journal:  Am J Obstet Gynecol       Date:  2016-03-10       Impact factor: 8.661

6.  Placental gene transfer: transgene screening in mice for trophic effects on the placenta.

Authors:  Anna B Katz; Sundeep G Keswani; Mounira Habli; Foong Y Lim; Philip W Zoltick; Paola Midrio; Elliot D Kozin; Meenhard Herlyn; Timothy M Crombleholme
Journal:  Am J Obstet Gynecol       Date:  2009-08-28       Impact factor: 8.661

Review 7.  Uteroplacental circulation and fetal vascular function and development.

Authors:  Kent L Thornburg; Samantha Louey
Journal:  Curr Vasc Pharmacol       Date:  2013-09       Impact factor: 2.719

8.  Role of the angiopoietin/Tie system in pregnancy (Review).

Authors:  D Kappou; S Sifakis; A Konstantinidou; N Papantoniou; D A Spandidos
Journal:  Exp Ther Med       Date:  2015-02-09       Impact factor: 2.447

Review 9.  Oxygen, the Janus gas; its effects on human placental development and function.

Authors:  Graham J Burton
Journal:  J Anat       Date:  2008-10-13       Impact factor: 2.610

10.  Secretion of soluble vascular endothelial growth factor receptor 1 (sVEGFR1/sFlt1) requires Arf1, Arf6, and Rab11 GTPases.

Authors:  Jae-Joon Jung; Ajit Tiwari; Shivangi M Inamdar; Christie P Thomas; Apollina Goel; Amit Choudhury
Journal:  PLoS One       Date:  2012-09-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.